Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world lemborexant effectiveness and safety in insomnia (China cohort)
ChiCTR2600116644Phase 4Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lemborexant in Insomnia (3 arms), sponsored by Xuanwu Hospital. Primary endpoint: Change in Insomnia Severity Index (ISI) score at 4 weeks. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2600116644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116644.